meta-analysis. Lancet . 2014;384:2228-2234. 19.Maiorino MI, Chiodini P, Bellastella G, Capuano A, Esposito K, Giugliano D. Insulin and glucagon-like peptide 1 receptor agonistcombination therapy in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care . 2017;40: 614-624. 20.Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab . 2016;18:401-409. 21.Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Are patients on basal insulin attaining glycemic targets? Characteris- tics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achiev- ing glycemic targets. Diabetes Res Clin Pract . 2016;121:17-26. 22.Rosenstock J, Fonseca VA, Gross JL, et al. Advancing basal insulin